05.03.2015 • News

DuPont Rejects Activist Investor’s Universal Ballot Request

DuPont has rejected a request from activist investor Nelson Peltz and his hedge fund Trian to use a universal ballot in an upcoming vote on candidates for the chemical producer's board of directors.

Trian has launched a proxy fight to take four of the seats on DuPont's 13-member board.

A universal ballot would put both Trian's four nominees and DuPont's full 13-member board on the same document sent to shareholders, rather than each side sending its own version.

While the traditional proxy process uses white cards containing the company-backed nominees or gold cards that list the shareholder nominees, the universal proxy allows shareholders to split their vote if they are not fully convinced of either party during a proxy battle.

"DuPont is forcing stockholders to elect either the Trian slate of candidates or the DuPont slate of candidates, rather than permitting stockholders to elect whichever candidates they prefer," Nelson Peltz said in a statement.

"We believe it would be inappropriate for a company with the size of our shareholder base to serve as a test case, especially as the matter at hand is so critical to the value of our shareholders' investment," DuPont said in a letter sent to Trian, pointing to concerns about its large base of retail investors.

With market capitalization of $71 billion, the chemical producer is one of the largest firms to be engaged in a proxy fight. Compatriot Dow Chemical sidestepped a fight with its own activist investor, Daniel Loeb and his Third Point hedge fund, through a last-minute compromise agreement.

A universal proxy could compromise access and accuracy and issuing the card to all 600,000 individual shareholders could be cumbersome, the chemical group added.

The universal ballot is said to have played a key role in two failed proxy fights of billionaire activist investor William Ackman, who recently also lost a battle for control over Botox manufacturer Allergan.

DuPont has yet to set a date for its annual meeting, but it is usually held in late April.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read